Back to Search
Start Over
Drug-induced esophagitis and helpful management for healthcare providers.
- Source :
- Gastroenterology & Hepatology from Bed to Bench; Summer2022, Vol. 15 Issue 3, p219-224, 6p
- Publication Year :
- 2022
-
Abstract
- In recent decades, the number of cases developing drug-induced esophagitis (DIE) has reportedly been growing, which indicates the significance of detecting medicines capable of causing this adverse reaction. This study aims to provide an updated review on recent case reports of DIE, to evaluate the possible mechanism of this side effect, and to provide helpful management. Data was gathered through searches of three databases, namely PubMed, Medline, and Cochrane. Seven drug categories were evaluated: antibiotics, bisphosphonates, cardiovascular medicines, chemotherapeutic agents, non-steroidal anti-inflammatory drugs (NSAIDs), other medications, and supplements. According to the findings, retrosternal pain, heartburn, odynophagia, and dysphagia are typical symptoms of DIE, and in most cases, DIE is a self-limiting side effect which can be resolved by removing the causative agent and providing supportive therapy. [ABSTRACT FROM AUTHOR]
- Subjects :
- ONLINE information services
MEDICAL databases
DIPHOSPHONATES
PAIN
SYSTEMATIC reviews
NONSTEROIDAL anti-inflammatory agents
ANTINEOPLASTIC agents
DEGLUTITION disorders
RISK assessment
CARDIOVASCULAR agents
DIETARY supplements
ESOPHAGUS diseases
DRUG side effects
MEDLINE
HEARTBURN
ANTIBIOTICS
DISEASE risk factors
Subjects
Details
- Language :
- English
- ISSN :
- 20082258
- Volume :
- 15
- Issue :
- 3
- Database :
- Complementary Index
- Journal :
- Gastroenterology & Hepatology from Bed to Bench
- Publication Type :
- Academic Journal
- Accession number :
- 159878584
- Full Text :
- https://doi.org/10.22037/ghfbb.v15i3.2591